Individual Variation in Tirzepatide Response: Who Benefits Most?

Analysis of individual variation in tirzepatide type 2 diabetes response identifies patient characteristics predicting who achieves the best glycemic and weight outcomes.

Aminorroaya, Arya et al.·Journal of the American College of Cardiology·2025·Strong EvidenceMeta-Analysis
RPEP-09928Meta AnalysisStrong Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Meta-Analysis
Evidence
Strong Evidence
Sample
N=large
Participants
Individual participants from 7 phase 3 tirzepatide RCTs across diverse subpopulations

What This Study Found

Analysis of individual variation in tirzepatide type 2 diabetes response identifies patient characteristics predicting who achieves the best glycemic and weight outcomes.

Key Numbers

7 phase 3 randomized clinical trials pooled using individual participant data. Published in the Journal of the American College of Cardiology.

How They Did This

In publication.

Why This Research Matters

Relevant to peptide therapeutics.

The Bigger Picture

Advances peptide evidence.

What This Study Doesn't Tell Us

In publication.

Questions This Raises

  • ?Long-term implications?
  • ?Evidence comparison?
  • ?Next steps?

Trust & Context

Key Stat:
Key finding Analysis of individual variation in tirzepatide type 2 diabetes response identifies patient characte
Evidence Grade:
Based on design.
Study Age:
Published in 2025.
Original Title:
Effects of Tirzepatide in Type 2 Diabetes: Individual Variation and Relationship to Cardiometabolic Outcomes.
Published In:
Journal of the American College of Cardiology, 85(19), 1858-1872 (2025)
Database ID:
RPEP-09928

Evidence Hierarchy

Meta-Analysis / Systematic ReviewCombines many studies into one answer
This study
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal Study

Combines results from multiple studies to find an overall pattern.

What do these levels mean? →

Frequently Asked Questions

What does this mean?

Analysis of individual variation in tirzepatide type 2 diabetes response identifies patient characteristics predicting who achieves the best glycemic and weight outcomes.

How reliable?

Consult publication.

Read More on RethinkPeptides

Cite This Study

RPEP-09928·https://rethinkpeptides.com/research/RPEP-09928

APA

Aminorroaya, Arya; Oikonomou, Evangelos K; Biswas, Dhruva; Jastreboff, Ania M; Khera, Rohan. (2025). Effects of Tirzepatide in Type 2 Diabetes: Individual Variation and Relationship to Cardiometabolic Outcomes.. Journal of the American College of Cardiology, 85(19), 1858-1872. https://doi.org/10.1016/j.jacc.2025.03.516

MLA

Aminorroaya, Arya, et al. "Effects of Tirzepatide in Type 2 Diabetes: Individual Variation and Relationship to Cardiometabolic Outcomes.." Journal of the American College of Cardiology, 2025. https://doi.org/10.1016/j.jacc.2025.03.516

RethinkPeptides

RethinkPeptides Research Database. "Effects of Tirzepatide in Type 2 Diabetes: Individual Variat..." RPEP-09928. Retrieved from https://rethinkpeptides.com/research/aminorroaya-2025-effects-of-tirzepatide-in

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.